You can also request for sample page of abovemention reports on firstname.lastname@example.org
Pages : 82PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $6000 |20% Off on above 1000$ Reports25% off on purchase of 2 reports and 30% on purchase of3 or more reports.Discount till 31st Dec. 2012.
Summary Global Markets Direct’s, Hereditary Angioedema (HAE) - Pipeline Review,H2 2012, provides an overview of the indication’s therapeutic pipeline. Thisreport provides information on the therapeutic development for HereditaryAngioedema (HAE), complete with latest updates, and special features onlate-stage and discontinued projects. It also reviews key players involved inthe therapeutic development for Hereditary Angioedema (HAE). HereditaryAngioedema (HAE) - Pipeline Review, Half Year is built using data andinformation sourced from Global Markets Direct’s proprietary databases,Company/University websites, SEC filings, investor presentations andfeatured press releases from company/university sites and industry-specificthird party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based onthe availability and relevance of data for the indicated disease.
Scope - A snapshot of the global therapeutic scenario for Hereditary Angioedema(HAE).- A review of the Hereditary Angioedema (HAE) products under development bycompanies and universities/research institutes based on information derivedfrom company and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Hereditary Angioedema (HAE).- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.- Plan mergers and acquisitions effectively by identifying players of the mostpromising pipeline.
Table of Contents : List of Tables 4List of Figures 5Introduction 6Global Markets Direct Report Coverage 6Hereditary Angioedema (HAE) Overview 7Therapeutics Development 8An Overview of Pipeline Products for Hereditary Angioedema (HAE) 8Hereditary Angioedema (HAE) Therapeutics under Development byCompanies 10Late Stage Products 11Comparative Analysis 11Mid Clinical Stage Products 12Comparative Analysis 12Early Clinical Stage Products 13Comparative Analysis 13Pre-Clinical Stage Products 14Comparative Analysis 14Hereditary Angioedema (HAE) Therapeutics – Products underDevelopment by Companies 15……………….
Please follow link if you want More RelatedReports :Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=PipelineReview, H2 2012&PubId=&pagenum=1
For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: email@example.com ,firstname.lastname@example.orgURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore